Thomas Trimarchi insider trades
Open-market stock purchases and sales by Thomas Trimarchi, President and CFO at BridgeBio Pharma, Inc, from SEC Form 4 filings since Aug 6, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 16, 2026 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $1.8M |
| May 18, 2026 | BBIO BridgeBio Pharma, Inc | Sold | $678K |
| May 18, 2026 | BBIO BridgeBio Pharma, Inc | Sold | $211K |
| May 16, 2026 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $1.5M |
| Mar 18, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc | Sold | $1M |
| Feb 17, 2026 | BBIO BridgeBio Pharma, Inc | Sold | $15.1K |
| Feb 16, 2026 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $1.4M |
| Dec 12, 2025 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $1M |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $660K |
| Nov 17, 2025 | BBIO BridgeBio Pharma, Inc | Sold | $465K |
| Nov 16, 2025 | BBIO BridgeBio Pharma, Inc | Sold (not open market) | $1.4M |
Companies traded
- BBIO BridgeBio Pharma, Inc: 9 sales, last Aug 16, 2026